Examining the safety profile of angiogenesis inhibitors: implications for clinical practice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 17762596 AND DT 2010 AND VI 5 AND IP 4
Results: 9
1
2
Use of rituximab in three children with relapsed/refractory Burkitt lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
4
Tufted hair folliculitis in a woman treated with trastuzumab.
- Published in:
- 2010
- By:
- Publication type:
- journal article
5
Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice.
- Published in:
- 2010
- By:
- Publication type:
- journal article
6
Targeting mTOR in cancer: renal cell is just a beginning.
- Published in:
- 2010
- By:
- Publication type:
- journal article
7
EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992.
- Published in:
- 2010
- By:
- Publication type:
- journal article
8
Personalized medicine in lung adenocarcinoma: no longer a hope or a passing fashion, but a new reality.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
9
Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
- Published in:
- 2010
- By:
- Publication type:
- journal article